JP2022543402A5 - - Google Patents

Info

Publication number
JP2022543402A5
JP2022543402A5 JP2022506712A JP2022506712A JP2022543402A5 JP 2022543402 A5 JP2022543402 A5 JP 2022543402A5 JP 2022506712 A JP2022506712 A JP 2022506712A JP 2022506712 A JP2022506712 A JP 2022506712A JP 2022543402 A5 JP2022543402 A5 JP 2022543402A5
Authority
JP
Japan
Prior art keywords
composition
use according
perfluorohexyloctane
isopropanol
latanoprost
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022506712A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022543402A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/072211 external-priority patent/WO2021028328A1/en
Publication of JP2022543402A publication Critical patent/JP2022543402A/ja
Publication of JP2022543402A5 publication Critical patent/JP2022543402A5/ja
Priority to JP2025129017A priority Critical patent/JP2025160428A/ja
Pending legal-status Critical Current

Links

JP2022506712A 2019-08-09 2020-08-06 プロスタグランジンアナログを含む局所組成物 Pending JP2022543402A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025129017A JP2025160428A (ja) 2019-08-09 2025-08-01 プロスタグランジンアナログを含む局所組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19191035.5 2019-08-09
EP19191035 2019-08-09
PCT/EP2020/072211 WO2021028328A1 (en) 2019-08-09 2020-08-06 Topical composition comprising a prostaglandin analogue

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025129017A Division JP2025160428A (ja) 2019-08-09 2025-08-01 プロスタグランジンアナログを含む局所組成物

Publications (2)

Publication Number Publication Date
JP2022543402A JP2022543402A (ja) 2022-10-12
JP2022543402A5 true JP2022543402A5 (enExample) 2023-08-17

Family

ID=67587648

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022506712A Pending JP2022543402A (ja) 2019-08-09 2020-08-06 プロスタグランジンアナログを含む局所組成物
JP2025129017A Pending JP2025160428A (ja) 2019-08-09 2025-08-01 プロスタグランジンアナログを含む局所組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025129017A Pending JP2025160428A (ja) 2019-08-09 2025-08-01 プロスタグランジンアナログを含む局所組成物

Country Status (8)

Country Link
US (2) US20220362382A1 (enExample)
EP (1) EP4009952A1 (enExample)
JP (2) JP2022543402A (enExample)
KR (1) KR20220044739A (enExample)
CN (1) CN114206344A (enExample)
AU (2) AU2020330424A1 (enExample)
CA (1) CA3144193A1 (enExample)
WO (1) WO2021028328A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2714010T3 (en) 2011-05-25 2017-06-12 Novaliq Gmbh TOPICAL PHARMACEUTICAL COMPOSITION BASED ON SEMIFLUORED ALKANES
CN110403923B (zh) 2015-09-30 2021-09-21 诺瓦利克有限责任公司 半氟化化合物和其组合物
EP4374851B1 (en) 2016-12-23 2026-04-15 Novaliq GmbH Ophthalmic composition for treatment of dry eye disease
WO2019068763A1 (en) 2017-10-04 2019-04-11 Novaliq Gmbh OPHTHALMIC COMPOSITIONS COMPRISING F6H8
SG11202007860XA (en) 2018-03-28 2020-09-29 Novaliq Gmbh Pharmaceutical composition comprising timolol
EP3923907B1 (en) 2019-02-13 2024-09-25 Novaliq GmbH Compositions and methods for the treatment of ocular neovascularization
KR20220058577A (ko) 2019-09-06 2022-05-09 노바리크 게엠베하 포도막염 치료를 위한 안과용 조성물
WO2025133899A1 (en) 2023-12-19 2025-06-26 Glenmark Specialty S.A. Topical composition comprising dutasteride and latanoprost for alopecia
WO2025149998A1 (en) * 2024-01-11 2025-07-17 Glenmark Specialty S.A. Topical composition comprising clascoterone and latanoprost for alopecia
WO2026013128A1 (en) * 2024-07-10 2026-01-15 Dermaliq Therapeutics, Inc. Treatment of androgenetic alopecia

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1021179B1 (en) * 1997-02-04 2004-05-12 Murray A. Johnstone Method of enhancing hair growth
JP2005225817A (ja) * 2004-02-13 2005-08-25 Jiyugaoka Clinic 睫毛用育毛剤
DK2498783T3 (en) * 2009-11-09 2018-12-10 Allergan Inc COMPOSITIONS AND PROCEDURES FOR STIMULATING HAIR GROWTH
US9149484B2 (en) * 2009-11-09 2015-10-06 Allergan, Inc. Compositions and methods for stimulating hair growth
PL2547323T3 (pl) * 2010-03-17 2016-07-29 Novaliq Gmbh Kompozycja farmaceutyczna do leczenia podwyższonego ciśnienia wewnątrzgałkowego
JP6023181B2 (ja) * 2011-05-25 2016-11-09 ノバリック ゲーエムベーハー 爪に投与するための医薬組成物
WO2013106565A1 (en) 2012-01-10 2013-07-18 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide f2 alpha agonists
EP2944324A1 (de) * 2014-05-13 2015-11-18 LTS LOHMANN Therapie-Systeme AG Verwendung von semifluorierten Alkanen in transdermalen therapeutischen Systemen
PT3442480T (pt) * 2016-06-23 2019-12-23 Novaliq Gmbh Método de administração tópica
MX2020003534A (es) * 2017-09-27 2020-07-29 Novaliq Gmbh Composiciones oftalmicas que comprenden latanoprost para usarse en el tratamiento de las enfermedades oculares.

Similar Documents

Publication Publication Date Title
JP2022543402A5 (enExample)
ES2198476T3 (es) Inhibidores de no-sintasa.
US20080275118A1 (en) Health and cosmetic composition and regime for stimulating hair growth and thickening on the head, including the scalp, eyelashes, and eyebrows, and which discourages hair loss
US4814351A (en) Scalp treatment
US20070134175A1 (en) Panthenol and natural organic extracts for reducing skin irritation
JPH11501941A (ja) カプサゼピンを含有する局所用組成物
BRPI1003209A2 (pt) mÉtodo de tratamento cosmÉtico e sistema de tratamento para tratar o couro cabeludo humano
JP2006515328A (ja) 哺乳類の発毛の調節
US5665335A (en) Combinations of vasoactive substances with fatty acids to prevent hair loss
KR960000855A (ko) L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제조성물
KR960010002A (ko) L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제 조성물
CN110693773A (zh) 防脱发或毛发生长促进用组合物
CA3034839A1 (en) Methods and compositions for treating cutaneous fungal infections
CN111936130B (zh) 包含锶和甲基磺酰基甲烷(msm)的局部制剂及治疗方法
BR102017003313A2 (pt) composição anticaspa e método para a prevenção, redução ou tratamento da caspa
KR960010003A (ko) L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제 조성물
JP2003530420A (ja) ケラチン物質の化粧処置におけるアルコールデヒドロゲナーゼ阻害剤の使用
BRPI0900541A2 (pt) composiÇço de cuidado das fibras queratÍnicas humanas, uso cosmÉtico e processo de tratamento cosmÉtico das fibras queratÍnicas humanas e/ou do couro cabeludo
JP2520700B2 (ja) 皮膚用の化粧品組成物
WO2021240505A1 (en) Compositions for treatment of psoriasis of the scalp
CN103732224B (zh) 用于眼睫毛生长的组合物
JPWO2013180229A1 (ja) 育毛用組成物
JP2004534069A (ja) No−シンターゼインヒビターとその用途
JPS62242608A (ja) 養毛化粧料
EA048692B1 (ru) Местные составы, содержащие стронций и метилсульфонилметан (мсм), и их применение